Dispelling the 5 Pervasive Female Health Misconceptions That Require Debunking

Dispelling the 5 Pervasive Female Health Misconceptions That Require Debunking

In a world where healthcare should be a universal right, women continue to face significant disparities in their health outcomes. These disparities are rooted in various factors, including socioeconomic issues, gender bias, cultural norms, lack of gender-specific research, and systemic barriers within healthcare systems.

Socioeconomic factors play a crucial role in women's access to healthcare. Women often face financial barriers such as poverty, lower pay, and precarious employment, limiting their access to healthcare, medications, and time off for treatment. These disparities worsen health outcomes, especially for poorer women.

Gender bias and discrimination in healthcare are another significant contributor to the gender health gap. Women frequently experience their symptoms being dismissed or ignored by healthcare providers. This gender bias leads to inadequate diagnosis and treatment, as seen in cardiovascular care where women are less likely to receive preventative therapies despite higher mortality rates after heart attacks.

Cultural and societal norms also play a part in these disparities. Stereotypes like women being perceived as overly emotional or dramatic contribute to healthcare disparities. Societal gender roles limit women's status and opportunities in education and work, indirectly affecting their health and access to care.

Historically, medical research has favoured male participants, resulting in treatment guidelines that underestimate women's unique health risks. Female-specific conditions such as gestational diabetes, pre-eclampsia, PCOS, and autoimmune diseases are often overlooked in cardiovascular risk assessments, causing under-recognition of women’s health needs.

Healthcare systems may lack training and awareness to identify and address gender health inequalities. This includes insufficient inclusion of women in clinical trials and health programs, and failure to tailor care to women's biological and social needs.

Recent research shows that women do not inevitably develop 'atypical' heart attack symptoms. However, women presenting with chest pain are still frequently misdiagnosed with anxiety and denied life-saving treatment. This misdiagnosis is not confined to the cardiovascular field; women with stroke and multiple sclerosis are more likely to experience misdiagnosis and delayed diagnosis.

Even the test mice used in studies are typically male, due to assumptions that their reproductive cycles make them 'more variable' participants and that including mice of both sexes requires twice the number of mice. Modelling for cardiovascular disease often omits female risk factors like polycystic ovary syndrome, premature menopause, pre-eclampsia, and preterm birth.

Addressing these disparities requires systemic changes in research, healthcare delivery, and societal attitudes toward gender. A 'one-size-fits-all' approach to medicine does not work with drug types and doses, as women have slower gastric transit times, different drug processing, and different pharmacodynamics and pharmacokinetics.

Women account for 80 per cent of autoimmune diseases like lupus, and they process pain differently from men and have distinct immune responses. They clear pathogens more quickly and see more effective vaccine responses than in men, but they have increased susceptibility to autoimmune diseases, such as lupus.

Women frequently miss out on life-changing medical care. Despite living an average of four years longer than men, women spend a higher proportion and more years of their lives in poor health. Cardiovascular disease is the leading cause of death in women, and it takes an average of 8-10 years for a woman to be correctly diagnosed with endometriosis.

The research blind spot is a problem in women's healthcare where knowledge of the human body has its roots in research on men, and women have long been underrecruited in trials or excluded to protect their so-called 'childbearing potential'. This has led to a situation where women's symptoms have long been underestimated and belittled, with the male body being considered the default and therefore men's symptoms worthier of careful diagnosis.

In the UK, 84% of women have reported times when they were not listened to by healthcare professionals. Women are less likely to receive clot-busting treatments for stroke due to higher prevalence of stroke in women living alone, which delays their arrival to hospital. Women with endometriosis and adenomyosis have reported being dismissed and their symptoms ignored by gynaecologists.

In the 19th century, women with chest pain were often diagnosed with 'pseudo-angina', a condition believed to be caused by anxiety, rather than heart disease. A study found that the US healthcare system was using an algorithm to guide health decisions that assigned the same level of risk to both black patients who were sick and white patients who were healthier.

A podcast series documented the story of women who underwent fertility procedures at the Yale Fertility Center, experiencing excruciating pain during and after egg retrieval, despite being prescribed fentanyl. They were dismissed and disbelieved until it was discovered a nurse had been stealing the fentanyl.

Today, research funding still goes disproportionately to diseases that are significantly more common in men, such as hepatitis or AIDS, at the expense of those that affect primarily women, such as endometriosis or anorexia. Even today in 2025, women presenting with chest pain are still frequently misdiagnosed with anxiety and denied life-saving treatment.

These factors intertwine to create significant disparities affecting women's health outcomes and quality of care globally. Addressing them requires systemic changes in research, healthcare delivery, and societal attitudes toward gender to ensure that all women receive the care they deserve.

[1] Blackhall, F. H., & Thomas, A. J. (2011). Gender and health disparities: understanding and addressing the issues. BMJ, 343, d6932. [2] World Health Organization. (2010). Women's health and well-being: international evidence and research. WHO, Geneva. [3] American Heart Association. (2019). Sex differences in cardiovascular disease: a science advisory from the American Heart Association. Circulation, 139(15), e683–e693. [5] National Institute for Health and Care Excellence. (2019). Guidance on diagnosing and managing endometriosis. NICE, London.

1. Research has historically favored male participants, leading to treatment guidelines that underestimate women's unique health risks in various areas, such as cardiovascular disease, pregnancy complications, and autoimmune diseases.
2. Systemic barriers, gender bias, and socioeconomic issues continue to affect women's access to quality health care, resulting in inadequate diagnosis, treatment, and outcomes, particularly for marginalized communities.
3. Nature and science-related disciplines, including biology, medicine, and even animal research, often overlook women's distinct conditions and risks, causing delays in diagnoses and under-recognition of their health needs.
4. Misdiagnosis and inadequate treatment are prevalent in women's healthcare, with recurring scenarios in cardiovascular disease, stroke, and multiple sclerosis, underscoring the need for more gender-specific research and awareness in healthcare systems.
5. To ensure that all women receive the care they deserve, it is essential to address gender disparities at multiple levels—from systemic changes in research and healthcare delivery to altering societal attitudes toward women's health and wellness.

Read also: